|
ZSCAN12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.562180E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.642900E-03 |
| Normal-vs-Stage2 |
5.948000E-01 |
| Normal-vs-Stage3 |
1.479650E-01 |
| Normal-vs-Stage4 |
1.896590E-01 |
| Stage1-vs-Stage2 |
4.628200E-01 |
| Stage1-vs-Stage3 |
7.109000E-01 |
| Stage1-vs-Stage4 |
7.991600E-01 |
| Stage2-vs-Stage3 |
6.426800E-01 |
| Stage2-vs-Stage4 |
5.271400E-01 |
| Stage3-vs-Stage4 |
7.007400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.082900E-03 |
| Normal-vs-AfricanAmerican |
3.428000E-01 |
| Normal-vs-Asian |
1.571920E-02 |
| Caucasian-vs-AfricanAmerican |
2.057200E-01 |
| Caucasian-vs-Asian |
3.806200E-01 |
| AfricanAmerican-vs-Asian |
2.606800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.020480E-02 |
| Normal-vs-Female |
5.991400E-01 |
| Male-vs-Female |
5.847700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.760000E-02 |
| Normal-vs-Extreme_Weight |
1.557720E-03 |
| Normal-vs-Obese |
3.272200E-01 |
| Normal-vs-Extreme_Obese |
2.339600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.112800E-01 |
| Normal_Weight-vs-Obese |
3.807200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.610200E-01 |
| Extreme_Weight-vs-Obese |
5.381800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.844000E-01 |
| Obese-vs-Extreme_Obese |
2.983600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.592060E-02 |
| Normal-vs-Age(41-60Yrs) |
5.077800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.736670E-03 |
| Normal-vs-Age(81-100Yrs) |
8.166000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.043800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.142800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.405600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.099000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.625900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.566400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.166370E-01 |
| Normal-VS-Type2 PRCC |
7.57989999999875E-05 |
| Normal-VS-KIRP CIMP |
7.80660000000433E-05 |
| Normal-VS-Unclassified PRCC |
8.896000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.554000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.370000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.680990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.007800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.321350E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.421320E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.379000E-04 |
| Normal-vs-N1 |
5.884600E-01 |
| Normal-vs-N2 |
3.622500E-03 |
| N0-vs-N1 |
1.489200E-01 |
| N0-vs-N2 |
1.454820E-01 |
| N1-vs-N2 |
7.540500E-03 |
|
|
